[ Price : $8.95]
FDA says Gentas Genasense is not approvable for use with chemotherapy in treating patients with chronic lymphocytic leukemia.[ Price : $8.95]
Federal Register Notice: FDA plans to take enforcement action against unapproved drug products containing quinine, quinine sulfate...[ Price : $8.95]
Federal Register Notice: FDA seeks written comments on World Health Organization recommendations to impose international manufactu...[ Price : $8.95]
Two FDA advisory committees vote against two of three indications for Sanofi-Aventis troubled antibiotic Ketek, and recommend a bl...[ Price : $8.95]
Elan Corp. and Biogen Idec file a supplemental BLA for Tysabri, indicated for treating moderate to severe active Crohns disease.[ Price : $8.95]
FDA approves seven changes to labeling for Bayers Trasylol.[ Price : $8.95]
The Government Accountability Office says FDAs inability to systematically determine which DTC ads to review and the length of tim...[ Price : $8.95]
Consulting editor John Scharmann receives an unsatisfactory response from CVM about its continued approval of growth-promotant ant...